Clinical trial
Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive…
NCT00381017 · Merck Sharp & Dohme LLC, Industry · Withdrawn
Key facts
| NCT number | NCT00381017 |
|---|---|
| Title | Effects of Low-dose Maintenance Peg Interferon Alfa-2b Therapy Versus Supportive Care in Patients With Cirrhotic Hepatitis C With HIV (Study P04371) |
| Official title | A Randomized, Open-label, Multi-center, Phase 3, 2-arm Study Evaluating the Efficacy and Safety of Peg Interferon Alfa-2b Low-dose Maintenance Monotherapy Versus Standard Supportive Care in Patients With Cirrhotic Hepatitis C Co-infected With Human Immunodeficiency Virus - The ENDURE Study |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Collaborators | Integrated Therapeutics Group Industry |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatitis C, Liver Cirrhosis, HIV Infections |
| Intervention type | Drug |
| Interventions | Peg interferon alpha-2b |
| Enrollment | 0 |
| Start date | Sep 1, 2006 |
| First posted | Sep 27, 2006 |
| Last update posted | Aug 13, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: